T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Tesla
TSLA
|
+$1.87B |
| 2 |
T-Mobile US
TMUS
|
+$1.53B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.43B |
| 4 |
Apple
AAPL
|
+$1.28B |
| 5 |
PepsiCo
PEP
|
+$1.1B |
Top Sells
| 1 |
Alphabet (Google) Class C
GOOG
|
+$3.16B |
| 2 |
Amazon
AMZN
|
+$3.02B |
| 3 |
GE Aerospace
GE
|
+$2.2B |
| 4 |
Goldman Sachs
GS
|
+$1.76B |
| 5 |
Salesforce
CRM
|
+$1.43B |
Sector Composition
| 1 | Technology | 30.27% |
| 2 | Healthcare | 17.75% |
| 3 | Financials | 11.3% |
| 4 | Consumer Discretionary | 11.17% |
| 5 | Communication Services | 8.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Maravai LifeSciences
MRVI
$404M
| $13.7M | ﹤0.01% |
974,740
+4,215
| +0.4% | +$59.1K |
|
1002
Fox Class A
FOXA
$28.7B
| $13.6M | ﹤0.01% |
398,001
-2,908
| -0.7% | -$99K |
|
1003
Carnival Corp
CCL
$44B
| $13.5M | ﹤0.01% |
1,331,601
+66,945
| +5% | +$680K |
|
1004
Fomento Económico Mexicano
FMX
$31.4B
| $13.4M | ﹤0.01% |
+140,600
| New | +$13.4M |
|
1005
iShares Core S&P 500 ETF
IVV
$675B
| $13.3M | ﹤0.01% |
32,451
+8,321
| +34% | +$3.42M |
|
1006
Orchestra BioMed
OBIO
$141M
| $13.3M | ﹤0.01% |
680,547
-5,254
| -0.8% | -$103K |
|
1007
Robert Half
RHI
$3.7B
| $13.2M | ﹤0.01% |
163,300
+3,038
| +2% | +$245K |
|
1008
Schrodinger
SDGR
$1.38B
| $13.1M | ﹤0.01% |
498,568
+469,872
| +1,637% | +$12.4M |
|
|
NVRO
1009
DELISTED
NEVRO CORP.
NVRO
| $13.1M | ﹤0.01% |
362,329
+81,895
| +29% | +$2.96M |
|
1010
Transocean
RIG
$3.07B
| $13M | ﹤0.01% |
2,039,368
+1,834,048
| +893% | +$11.7M |
|
1011
Molson Coors Class B
TAP
$9.71B
| $12.9M | ﹤0.01% |
250,032
+7,050
| +3% | +$364K |
|
1012
Vistra
VST
$69.1B
| $12.7M | ﹤0.01% |
530,378
-340,007
| -39% | -$8.16M |
|
1013
American Airlines Group
AAL
$8.54B
| $12.6M | ﹤0.01% |
855,206
+19,905
| +2% | +$294K |
|
|
OZON
1014
DELISTED
Ozon Holdings PLC American Depositary Shares, each ADS representing one ordinary share
OZON
| $12.6M | ﹤0.01% |
1,798,842
-1,226,514
| -41% | -$8.59M |
|
1015
Ardagh Metal Packaging
AMBP
$2.14B
| $12.6M | ﹤0.01% |
3,079,617
+41,949
| +1% | +$171K |
|
1016
Dorman Products
DORM
$5B
| $12.5M | ﹤0.01% |
145,066
-126,550
| -47% | -$10.9M |
|
1017
Tenaya Therapeutics
TNYA
$209M
| $12.5M | ﹤0.01% |
4,386,783
-85,419
| -2% | -$243K |
|
|
BWIN
1018
Baldwin Insurance Group
BWIN
$2.21B
| $12.3M | ﹤0.01% |
484,866
+1,671
| +0.3% | +$42.5K |
|
1019
HEICO
HEI
$44.7B
| $12.3M | ﹤0.01% |
71,868
+56,526
| +368% | +$9.67M |
|
1020
Ardelyx
ARDX
$1.61B
| $12.3M | ﹤0.01% |
2,561,796
+265,370
| +12% | +$1.27M |
|
1021
KBR
KBR
$6.38B
| $12.2M | ﹤0.01% |
220,806
+161,275
| +271% | +$8.88M |
|
1022
Universal Health Services
UHS
$12.1B
| $12M | ﹤0.01% |
94,440
-153
| -0.2% | -$19.4K |
|
1023
NRG Energy
NRG
$30.5B
| $11.9M | ﹤0.01% |
346,612
+3,474
| +1% | +$119K |
|
1024
Tandem Diabetes Care
TNDM
$864M
| $11.8M | ﹤0.01% |
291,191
+925
| +0.3% | +$37.6K |
|
1025
Pentair
PNR
$18.5B
| $11.8M | ﹤0.01% |
213,460
+5,958
| +3% | +$329K |
|